摘要
背景:嗜铬粒蛋白A(CGA)及其衍生片段的研究令人信服地证明了21位氨基酸肽命名为Catestatin(CST:人CGA352-372,牛CGA344-364,大鼠CGA367-387)的多功能活性。这项审查旨在提供关于科学和技术委员会在健康和疾病方面的生物学作用的现有信息的概要。 方法:对同行评议研究文献的书目数据库进行结构搜索。 结果:CST主要被认为是烟碱依赖性儿茶酚胺(CA)释放的抑制剂和抗高血压肽,但其作用包括抗氧化剂和免疫防御,表皮功能和脂肪组织体内平衡的调节。 CST影响心脏循环系统间接作用,通过自主神经系统,直接影响基础心脏功能和拉伸依赖性心肌表现。它还抵消肾上腺素刺激对心脏的影响,并保护心肌免受缺血/再灌注损伤(I / R)的损伤,起到后期和后期保护作用。 结论:由于越来越多的人类研究证明其参与生理调节和许多严重疾病,CST的知识不断扩大,也揭示了其作为临床生物标志物的应用潜力。
关键词: 嗜铬粒蛋白A,催眠素,心肌表现,心脏保护,信号转导,生物作用,抗微生物肽,先天免疫,脂肪,表皮功能,肠道疾病。
Current Medicinal Chemistry
Title:Biological Roles of the Eclectic Chromogranin-A-derived Peptide Catestatin
Volume: 24 Issue: 31
关键词: 嗜铬粒蛋白A,催眠素,心肌表现,心脏保护,信号转导,生物作用,抗微生物肽,先天免疫,脂肪,表皮功能,肠道疾病。
摘要: Background: Research on Chromogranin A (CGA) and its derived fragments convincingly demonstrated the multifunctional activity of the 21 amino acid peptide named Catestatin (CST: human CGA352-372, bovine CGA344-364, rat CGA367-387). This review aims to provide a synopsis of the current information concerning the biological role of CST in health and disease.
Methods: Structured search of bibliographic databases for peer-reviewed research literature.
Results: CST is mainly known as an inhibitor of the nicotinic-dependent Catecholamine (CA) release, and an anti-hypertensive peptide, but its role includes a modulation of antioxidant and immune defense, epidermal function, and adipose tissue homeostasis. CST influences the cardiocirculatory system acting both indirectly, via the autonomic nervous system, and directly by influencing the basal cardiac function, and the stretch-dependent myocardial performance. It also counteracts the effects of adrenergic stimulation on the heart and protects the myocardium from ischemia/reperfusion (I/R) injury, acting in pre- and postconditioning protection.
Conclusions: The knowledge on CST is constantly expanding, thanks to a growing number of human studies that document its involvement in physiological modulation and in many severe diseases, also revealing its applicative potential as a clinical biomarker.
Export Options
About this article
Cite this article as:
Biological Roles of the Eclectic Chromogranin-A-derived Peptide Catestatin, Current Medicinal Chemistry 2017; 24 (31) . https://dx.doi.org/10.2174/0929867324666170616104759
DOI https://dx.doi.org/10.2174/0929867324666170616104759 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Multifactorial Regulation of GPER Expression in Cancer Cells and Cardiomyocytes
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Anti-Inflammatory Activities of Some Bee Products by Inhibition of Bovine Testes Hyaluronidase
Current Enzyme Inhibition The Metabolic Syndrome and HIV Infection
Current Pharmaceutical Design Inhibitors of the Microsomal Prostaglandin E2 Synthase-1 as Alternative to Non Steroidal Anti-Inflammatory Drugs (NSAIDs) – A Critical Review
Current Medicinal Chemistry Quantitative Analysis of Uric Acid Metabolites in Urine by High Performance Liquid Chromatography - Mass Spectrometry Using Silica Hydride Columns
Current Chromatography Quercetin-Phospholipid Complex: An Amorphous Pharmaceutical System in Herbal Drug Delivery
Current Drug Discovery Technologies Canagliflozin : A New Hope in the Antidiabetic Armamentarium
Recent Patents on Cardiovascular Drug Discovery The Relevance of Long-Term Adherence to Non-Pharmacological and Pharmacological Treatment of Hypertension
Current Hypertension Reviews Tear Film, Conjunctival and Corneal Modifications Induced by Glaucoma Treatment
Current Medicinal Chemistry Anti-miRNA-23a Oligonucleotide Suppresses Glioma Cells Growth by Targeting Apoptotic Protease Activating Factor-1
Current Pharmaceutical Design New Technologies for the Diagnosis of Sleep Apnea
Current Hypertension Reviews Functional Foods: Salient Features and Clinical Applications
Current Drug Targets - Immune, Endocrine & Metabolic Disorders ACE Inhibitory Peptides Derived from Aquatic Protein
Current Protein & Peptide Science Early Brain Injury or Vasospasm? An Overview of Common Mechanisms
Current Drug Targets Targeted Renal Delivery of Protein Kinase Inhibitors for the Treatment of Chronic Kidney Disease
Current Signal Transduction Therapy COX-Inhibiting Nitric Oxide Donors (CINODs): Potential Benefits on Cardiovascular and Renal Function
Cardiovascular & Hematological Agents in Medicinal Chemistry The Roles of Vitamin D and Its Analogs in Inflammatory Diseases
Current Topics in Medicinal Chemistry Investigation on the Development of Losartan Potassium Sustained Release Microspheres by Solvent Evaporation Methods
Micro and Nanosystems Editorial [Hot Topic:Metalloproteinases Revisited (Guest Editor: Marcia L. Moss)]
Current Pharmaceutical Biotechnology Procyanidins and Their Healthy Protective Effects Against Type 2 Diabetes
Current Medicinal Chemistry